
Fumiko Ladd Chino/bumpintheroad.us
Apr 25, 2025, 08:19
Fumiko Ladd Chino: It’s important to publish negative trials. AI cannot solve EVERYthing
Fumiko Ladd Chino, Radiation Oncologist at MD Anderson Cancer Center, shared a post on X:
“Emails to academic medical oncologists with info about genomically matched therapeutic #clinicaltrials for pts with tumor progression based on AI interpretation of imaging reports did NOT increase trial enrollment.
It’s important to publish negative trials. AI cannot solve EVERYthing.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 25, 2025, 07:53
Apr 25, 2025, 07:41
Apr 25, 2025, 07:11